Cloud Pharmaceuticals
Business Services · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6 Davis Dr, Durham, North Carolina, 2770...Phone Number
(910) 398-1200Website
www.cloudpharmaceuticals.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cloud Pharmaceuticals
Cloud Pharmaceuticals is a leader in artificial intelligence-based drug discovery and development, specializing in the use of Generative AI throughout the drug development process. The company collaborates with clients in the pharmaceutical, biotechnology, and medical research sectors to assist in molecule design, preclinical research, and clinical study planning. With a commitment to transforming drug development through AI, Cloud Pharmaceuticals aims to enhance the cost, speed, and success rates of creating novel therapies. They are also focused on building a unique data center dedicated to Generative AI model development and training.Explore more
Cloud Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cloud Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cloud Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Cloud Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Cloud Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Cloud Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Cloud Pharmaceuticals
Check out if Cloud Pharmaceuticals is spiking on competitors!
Cloud Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Cloud Pharmaceuticals has new funding data
Recommended Actions
Find VP level buyers at Cloud Pharmaceuticals
Find more new buyers
Compare Similar Companies to Cloud Pharmaceuticals
Compare insights from companies similar to Cloud Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cloud Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cloud Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cloud Pharmaceuticals.
Cloud Pharmaceuticals financials insights
Gather financial insights about Cloud Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Private Equity
$690K
2014
Angel/Seed
$1.5M
Cloud Pharmaceuticals Tech Stack
A closer look at the technologies used by Cloud Pharmaceuticals
See more technologies
Cloud Pharmaceuticals News & Media
Artificial Intelligence in Drug Discovery Market Insights with Latest Statistics and Growth Prediction to 2027 : NVIDIA Corporation, Deep Genomics, Cloud Pharmaceuticals
New York, NY -- (SBWIRE) -- 11/19/2020 -- The Global Artificial Intelligence in Drug Discovery Market Research Report offers an in-depth analysis of the Artificial Intelligence in Drug Discovery industry and the economic scenario for business management that offers development and profitability for the key players in the market. Read the full press release at http://www.sbwire.com/press-releases/artificial-intelligence-in-drug-discovery-market-insights-with-latest-statistics-and-growth-predictioArtificial Intelligence (AI) in Drug Discovery Market Size, Share 2020-2027: Industry Analysis by CAGR of 40.5%, Growth & Opportunities, Upcoming Trends, Latest Innovation by Microsoft, IBM, NVIDIA, Cloud Pharmaceuticals
SAN FRANCISCO, Sept. 07, 2020 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Drug Discovery Market Size" Study has been added to DBMR database. This report consists of information about historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. This report also provides an overview of industry, future trends, size, share, key player’s analysis with respect to Artificial Intelligence (AI) in DrugCloud Pharmaceuticals to Present AI-Based Drug Design at Conferences in May
COO Don Van Dyke to describe company technology and achievements in designing small molecule and peptide agents. RESEARCH TRIANGLE PARK, NC, UNITED STATES, April 30, 2019 /EINPresswire.com/ -- Don Van Dyke, COO of Cloud Pharmaceuticals Inc., an …Cloud Pharmaceuticals Wins U.S.-China Health Summit
Cloud Pharmaceuticals was selected to travel and present in Chengdu, Sichuan Oct. 14 2018 against 3 other US teams and 5 from China. Cloud took first place. RESEARCH TRIANGLE PARK, NC, USA, October 24, 2018 /EINPresswire.com/ -- Cloud Pharmaceuticals, a …
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cloud Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Cloud Pharmaceuticals is a leader in artificial intelligence-based drug discovery and development, specializing in the use of Generative AI throughout the drug development process. The company collaborates with clients in the pharmaceutical, biotechnology, and medical research sectors to assist in molecule design, preclinical research, and clinical... Read More
